ArticleCase reports in oncology
Recurrent High-Risk Neuroblastoma in an Adult Woman 28 Years following Curative Treatment.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neuroblastoma is a common pediatric solid tumor that frequently presents with high-risk disease. Case Presentation: An adult woman with a remote history of childhood neuroblastoma at age two presented to the hospital with spinal cord compression. She was ultimately diagnosed with metastatic neuroblastoma 28 years following her initial diagnosis. The patient had previously been in sustained remission, was functional and actively working, and had undergone follow-up in a cancer survivorship clinic. To our knowledge, this is the longest reported period from remission of neuroblastoma to recurrence, as the patient was well into adulthood at the time of diagnosis. Moreover, she presented with florid disease, characterized by diffuse osseous, solid organ involvement, and progressive cytopenia. She was treated with chemotherapy but developed multiple complications. Conclusion: This report illustrates an exceptionally rare late presentation of recurrent high-grade neuroblastoma, treatment course, and clinical outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.